Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sigachi IndustriesBOM:543389 -2.75%85 ROC (Joel Greenblatt) % is 10.70% as of Jun. 2026, which is 66% below its 10-year median of 31.65. GuruFocus rates BOM:543389 with a GF Score™ of 85/100 and a GF Value™ of ₹46.97 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 980 Drug Manufacturers companies, Sigachi Industries ranks worse than 56.33% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Sigachi Industries's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 10.70%.
The historical rank and industry rank for Sigachi Industries's ROC (Joel Greenblatt) % or its related term are showing as below:
BOM:543389'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -13.58 Med: 31.65 Max: 44.77
Current: 7.14
During the past 8 years, Sigachi Industries's highest ROC (Joel Greenblatt) % was 44.77%. The lowest was -13.58%. And the median was 31.65%.
BOM:543389's ROC (Joel Greenblatt) % is ranked worse than 56.33% of 980
companies
in the Drug Manufacturers industry
Industry Median: 10.885
vs BOM:543389: 7.14
Sigachi Industries's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Sigachi Industries ROC (Joel Greenblatt) % Related Terms
Sigachi Industries ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Sigachi Industries's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543389 vs ZTS: ROC (Joel Greenblatt) % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sigachi Industries's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sigachi Industries ROC (Joel Greenblatt) % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sigachi Industries's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Sigachi Industries's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 10.70% mean?
Sigachi Industries (BOM:543389) has a ROC (Joel Greenblatt) % of 10.70% as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Sigachi Industries and its competitors. This is 66% below median its historical median of 31.65. According to the industry distribution chart, Sigachi Industries ranks #552 out of 980 companies in the Drug Manufacturers industry, placing it in the top 56.3%.
Is Sigachi Industries' ROC (Joel Greenblatt) % too high?
Sigachi Industries' current ROC (Joel Greenblatt) % of 10.70% is 66% below median its 10-year median of 31.65. The Drug Manufacturers industry median ROC (Joel Greenblatt) % is 10.89. Sigachi Industries' value of 10.70% is 1.7% below this industry median. Based on the distribution chart, Sigachi Industries ranks #552 out of 980 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Sigachi Industries has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sigachi Industries' ROC (Joel Greenblatt) % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sigachi Industries ranks #552 out of 980 companies for ROC (Joel Greenblatt) %. This places Sigachi Industries in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 10.89. Sigachi Industries' value of 10.70% is 1.7% below this benchmark. While the company's 10-year median is 31.65 vs. the industry median of 10.89, Sigachi Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Drug Manufacturers company?
The median ROC (Joel Greenblatt) % among Drug Manufacturers companies is 10.89, based on 980 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sigachi Industries's current ROC (Joel Greenblatt) % of 10.70% is 1.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Sigachi Industries and its competitors. For the Drug Manufacturers industry, the median ROC (Joel Greenblatt) % is 10.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sigachi Industries's current ROC (Joel Greenblatt) % is 10.70%, which is 66% below median its own 10-year median of 31.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigachi Industries stock overvalued right now?
Based on GuruFocus' analysis, Sigachi Industries (BOM:543389) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹46.97, compared to a current price of ₹31.77 — trading 32.4% below its estimated fair value. The current ROC (Joel Greenblatt) % is 10.70%, which is 66% below median its 10-year median of 31.65 and 1.7% below the Drug Manufacturers industry median of 10.89. Sigachi Industries' overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Sigachi Industries (BOM:543389), the current ROC (Joel Greenblatt) % is 10.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sigachi Industries (BOM:543389) Overvalued in 2026?
Based on GuruFocus' analysis, Sigachi Industries stock appears to be undervalued.
The current stock price of ₹31.77 is trading 32.4% below its estimated GF Value™ of ₹46.97.
GuruFocus considers Sigachi Industries to be Significantly Undervalued.
Key valuation signals for BOM:543389:
ROC (Joel Greenblatt) %: 10.70% (66% below median its 10-year median of 31.65)
GF Value™: ₹46.97 vs. price of ₹31.77 (32.4% below fair value)
Industry Position: 1.7% below the Drug Manufacturers median (#552 of 980)
No single metric tells the full story. See the BOM:543389 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sigachi Industries Ltd is engaged in the manufacturing of Microcrystalline Cellulose (MCC), which is widely used as an excipient for finished dosages in the pharmaceutical industry. The Company is mainly pursuing only one activity which is manufacturing and selling of MCC. The company manufactures MCC of various grades ranging from 15 microns to 250 microns and the crucial grades of MCC manufactured and marketed by the company are branded as HiCel and AceCel.
85GF Score
Get the complete analysis for BOM:543389
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543389 has been successfully added to your 
